LKFT:VIE
Lakefront Biotherapeutics NV
€26.48
arrow_upward
+0.08%(+0.020) 1D
Oct 13, 1:00:32 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LKFT...
Open
€26.42
High
€26.48
Low
€26.42
Mkt. cap
1.74B
Avg. vol.
75.00
Volume
0.00
52-wk high
€27.58
52-wk low
€22.66
No. of employees
196
Open
€26.42
High
€26.48
Low
€26.42
Mkt. cap
1.74B
Avg. vol.
75.00
Volume
0.00
52-wk high
€27.58
52-wk low
€22.66
No. of employees
196
News stories
From web sources and news partners
Morningstar
·
48 minutes ago
XCF Global (Nasdaq:SAFX) Announces $12M+ in Gross Product Sales and Shipments of 1.4 Million Gallons of Renewable Diesel in September
FinancialContent
·
18 minutes ago
Albertsons (NYSE:ACI) Reports Q3 CY2026 In Line With Expectations
MarketBeat
·
8 minutes ago
Syndax Pharmaceuticals (NASDAQ:SNDX) Given Buy Rating at HC Wainwright
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com